🛡️
Intellectual-property status
The HEALTHx concept is currently under intellectual-property protection review at King Abdulaziz University — Innovation & Entrepreneurship Center. Status: under review.
🎓
Research already in motion
A master’s student is currently working on a defined component of the broader HEALTHx concept. The project is intentionally designed to support further theses, prototypes and joint research.
Why it matters
Universities create medical value. HEALTHx helps it travel.
Clinical teams routinely produce protocols, algorithms, operational know-how and research outputs with value beyond a single hospital. HEALTHx provides the translation layer between knowledge creation and market adoption—without turning the platform into a patient-data marketplace.
ClinicalStarts from real healthcare expertise
DigitalTransforms knowledge into scalable assets
ProtectedBuilds around IP and governance
CollaborativeLinks students, researchers and industry
The model
One innovation engine. Four value transitions.
01
Discover the innovation
Capture protocols, diagnostic logic, clinical workflows, research outputs and digital-health ideas in a structured form.
02
Translate with AI
Explain the value, identify use cases, prepare multilingual investor-facing material and map potential product forms.
03
Protect & govern
Keep ownership, disclosure, licensing logic, privacy and approval gates visible before commercialization.
04
Scale through partners
Connect validated innovations with hospitals, technology companies, researchers, students and investors.
What can become an asset?
More than apps.
🧠
Clinical algorithms
Decision logic, diagnostic support and predictive models that can become software, APIs or validated modules.
🩺
Treatment protocols
Structured pathways that can be digitized, localized, licensed, evaluated and embedded into care delivery.
📊
Research outputs
Methods, models, evidence summaries and analytic tools that can move toward translational or commercial use.
⚙️
Hospital know-how
Operational innovations in scheduling, resource use, quality, safety and workflow optimization.
🌐
Digital services
Remote advisory, analytics and expert services delivered as project-based or recurring offerings.
🤝
Co-development opportunities
Early concepts that need technical, clinical, regulatory or commercial partners to reach the next milestone.
For investors & industry
A platform thesis built around repeatable commercialization.
HEALTHx is not positioned as a single medical product. It is a repeatable commercialization architecture designed to continuously surface, structure, protect and connect multiple medical innovations.
Portfolio, not one bet
The model can host multiple innovations across specialties, creating diversified opportunity rather than dependence on one product.
University-originated pipeline
Clinical and research environments can provide a recurring source of problems, ideas, expertise and validation opportunities.
Multiple deal structures
Licensing, co-development, SaaS, research collaboration, consulting and startup formation can coexist under one platform logic.
De-risk through stages
Ideas can be filtered through IP, evidence, technical readiness and partnership gates before larger investment commitments.
Investor note: financial figures shown in earlier concept material are illustrative scenarios, not audited forecasts or guaranteed returns. The current priority is validation of the operating model, IP pathway and high-value pilot opportunities.
For students & researchers
A living research platform, not a closed project.
Master’s work is already underway.
A master’s student is working on one component of the broader HEALTHx idea. This creates a practical foundation for additional academic work while preserving clear boundaries around ownership, scope and contribution.
We welcome collaboration from students, faculty, clinicians, designers, engineers and industry researchers who can advance a defined part of the platform.
Responsible by design
Innovation without treating patient identity as a product.
🔐
Privacy-first scope
The commercialization target is knowledge, innovation and digital-health capability—not publication of patient-identifying information.
🧭
Governance gates
Clinical, legal, ethical and IP review can be built into the path from idea to external partnership.
✅
Evidence before claims
Performance and commercial claims should be supported by appropriate validation before external use.
Open collaboration
Have a clinical problem, research capability or investment thesis that fits?
We welcome focused collaboration with students, researchers, clinicians, health-tech companies and investors. The best starting point is a clearly defined component, pilot, dataset, validation question or commercialization pathway.
Intellectual-property wording reflects the current status described by the project owner: under review at King Abdulaziz University, Innovation & Entrepreneurship Center. It does not imply final patent grant, registration or commercial approval.